21-May-2020 | Facts and Factors
Findings from Facts and Factors has authored “Inflammatory Bowel Disease Treatment Market By Product (Crohn Diseases and Ulcerative Diseases), By Route of Administration (Orals and Parental) By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Others Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026”. states that the global Inflammatory Bowel Disease market in 2019 is approximately USD 15,509.22 Million. The market is anticipated to grow at a CAGR of 4.41% and is projected to reach around USD 21,888.23 Million by 2026.
Inflammatory bowel disease is an intestinal disorder characterized by chronic inflammation of the digestive tract. They are two type’s ulcerative colitis and Crohn’s disease. According to data, inflammatory bowel diseases affect at least 1.6 Million American and these people age below 35. This disorder comes under the category of chronic; life longing conditions and can be treated by medicine easily. These types of disorders mainly affect the quality of the life and sometimes affect the individual financially.
In Crohn’s disease, any part of the GI tract can be affected, starting from the mouth to the anus, but the most common part includes the end of the small intestine. In Ulcerative colitis, a mostly large part of the intestine is affected. Physicians prescribe injectables and oral drugs as a part of the therapy.
Browse the full “Inflammatory Bowel Disease Treatment Market By Product (Crohn's Diseases and Ulcerative Diseases), By Route of Administration (Orals and Parentals) By Distribution channel (Hospitals Pharmacy, Retail Pharmacy, and Others Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026" https://www.fnfresearch.com/inflammatory-bowel-disease-treatment-market-by-product-crohn
The market is driven by increasing awareness across the world. In addition, increasing effective treatment is also considered one of the major driving factors for the growth of the market. The financial burden on individuals is one of the major factors affecting the growth of the market. High per-capita healthcare expenditure in developed countries coupled with increasing per capita income and public awareness in the developing market of Asia Pacific will bring huge opportunities for the market within the forecast period.
In product type, the market is classified into two types Crohn’s disease and Ulcerative colitis. Crohn’s diseases hold the largest market share in the year 2019. People suffering from Crohn’s disease are comparatively larger than ulcerative colitis. It is estimated that Crohn’s accounts for approximately more than 65% of the market shares in the year 2019.
Based on the type of route of drug administration, the market is fragmented into two types: oral and injectables. Anti-inflammatory drugs are mostly prescribed to patients suffering from ulcerative colitis and given orally. Other drugs commonly prescribed are corticosteroids, antibiotics, immune modulators, and other biologic therapies. The site of administration depends upon the type of the drug and other various factors like drug efficacy and patient age and others.
Based on end-users, the market is classified into hospital pharmacies, retail Pharmacies, and other pharmacies. Hospital pharmacies held the largest market share in the year 2019. Hospital pharmacy is the major distributor of drugs to patients and thus acquired the largest market shares.
In general, the report is classified into five regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America accounts for the largest market share in the year 2019. This growth will remain to continue within the forecast period. Growth is mainly due to the presence of healthcare infrastructure in this region. In addition, rising per capita healthcare expenditure is the major factor for the growth of this region. Europe region is mainly dominated by Countries like the UK, Germany, France, Italy, and Others.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 15,509.22 Million |
Projected Market Size in 2026 |
USD 21,888.23 Million |
CAGR Growth Rate |
4.41% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
Johnson & Johnson Services Inc.; Pfizer Inc.; AbbVie Inc.; Takeda Pharmaceutical Company Limited, Celltrion Healthcare Co., Ltd.; CELGENE CORPORATION; COSMO PHARMACEUTICALS; Innovate Biopharmaceuticals; UCB S.A.; and Gilead Sciences., and others. |
Key Segment |
By Product, Route of Administration, Application, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Some of the most important market players in the global Inflammatory Bowel Disease Treatment market are Johnson & Johnson Services Inc.; Pfizer Inc.; AbbVie Inc.; Takeda Pharmaceutical Company Limited, Celltrion Healthcare Co., Ltd.; CELGENE CORPORATION; COSMO PHARMACEUTICALS; Innovate Biopharmaceuticals; UCB S.A.; and Gilead Sciences.
The taxonomy of the Inflammatory Bowel Disease Treatment Market by its scope and segmentation is as follows:
Global Inflammatory Bowel Disease Treatment Market: Product Segment Analysis
- Crohn’s disease
- Ulcerative colitis
Global Inflammatory Bowel Disease Treatment Market: Route of Administration Segment Analysis
- Injectables
- TNF-inhibitors
- IL inhibitors
- Anti-integrin
- Others
- Oral
- ASAs
- Corticosteroids
- JAK inhibitors
- Others
Global Inflammatory Bowel Disease Treatment Market: Application Segment Analysis
- Hospital Pharmacy
- Retail Pharmacy
- Others Pharmacy
Global Inflammatory Bowel Disease Treatment Market: By Region Segment Analysis
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- The Middle East & Africa
- GCC Countries
- South Africa
Rest of the Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
